Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages



Expert Says New FDA-Approved Painkiller “Will Kill People”


SKULL_RX_iStock_000007073329Large The FDA has approved Zohydro, a new extended-release painkiller that is 5 to 10 times more powerful than the amount of hydrocodone found in Vicodin. Critics are warning only two pills of this chillingly potent medication can kill. Why has the FDA, an agency entrusted to safeguard public health, allowed this drug on the market?

Needless to say, the green light given to Zohydro has ignited a furor among groups gravely concerned about its safety. Headlines from news organizations from across the country blare the alarm felt by many who are calling the pill ‘truly frightening’ and ‘deadly dangerous.’

Opposition to FDA Decision Is Widespread and Vehement

Public opposition of the drug’s approval is sweeping. In fact, in a strongly worded letter to the FDA, more than 40 experts urged the FDA to reverse its decision. “In the midst of a severe drug epidemic fueled by overprescribing of opioids, the very last thing the country needs is a new, dangerous, high-dose opioid,” the coalition wrote. One person who signed the letter, Dr. Andrew Kolodny, president of the advocacy group Physicians for Responsible Opioid Prescribing, bluntly predicted Zohydro “will kill people as soon as it’s released.”

Government entities are requesting the FDA to reconsider as well. Twenty-nine state attorneys general sent the FDA a similar letter in December, while members of congress asked the agency last November to review its approval ruling. The FDA’s decision even goes against the recommendation of its own advisory panel, who voted 11 to 2 for refusal of the new drug application for Zohydro.

What’s All the Fuss About?

Like OxyContin, Zohydro is a highly addictive opioid and a pure narcotic. But, unlike OxyContin, Zohydro isn’t tamper resistant, and can easily be crushed, a factor that would allow it to be snorted or injected.

The Centers for Disease Prevention and Control reports deaths from prescription opioids have quadrupled in recent years, skyrocketing from 4,030 in the year 1999 to 16,651 in 2010. Experts fear Zohydro’s potency and abuse potential will cause a quick rise in these grim overdose statistics.

Successful Clinical Trials or Cheating?

The clinical trials on Zohydro used a controversial method called enriched enrollment, a process that lets drug companies avoid testing a product on patients who don’t respond well to a medication or who are unable to tolerate its use. This approach is criticized because it is a way of making a drug seem more effective and enhances its chances of approval. Some call this method cheating, and rightly so, as it doesn’t accurately represent the drug’s effect on the general population.

Something Smells Fishy

Why did the FDA make such a seemingly insupportable decision to approve such a drug? Allegations have arisen over a possible conflict of interest between the federal agency and Elan Corp, Zohydro’s original manufacturer. In response to a Freedom of Information Act request, last fall several emails were made public that cast doubt on the presumed integrity of the FDA’s ruling. The emails indicated professors from the University of Rochester Medical Center arranged private meetings between FDA officials and pharmaceutical companies who manufacture pain medication.

This raises red flags because the drug firms paid the professors $20,000 to $35,000 to attend the meetings, and one of the companies present was Elan Corp. Zogenix, the current manufacturer of Zohydro wasn’t in the picture yet, but the company later partnered with Elan.

Kolodny tells NPR News that the revelation of these emails produced “a sense of ah-ha” among opponents of the drug’s approval. Senators David Vitter and Joe Manchin are seeking the answer to why the drug companies paid these sums. FDA officials who are involved in the approval process for prescription painkillers should not be receiving large amounts of money from drug firms, Vitter said. “If these allegations are true, there is a clear, illegal conflict of interest between the FDA and these pharmaceutical companies that puts consumer safety at risk,” he adds.


Mary West is a natural health enthusiast, as she believes this area can profoundly enhance wellness. She is the creator of a natural healing website where she focuses on solutions to health problems that work without side effects. You can visit her site and learn more at Ms. West is also the author of Fight Cancer Through Powerful Natural Strategies.

Healthy Living Starts Here

Never miss out on valuable information. Subscribe to our newsletter today!

Leave a Comment Below

4 responses to “Expert Says New FDA-Approved Painkiller “Will Kill People””

  1. fran dellmyer says:

    Let’s get rid of all these people working for the FDA and get some honest people who believe in natural health care and not being paid off by the big drug companies. How many more people are going to become addicts from these medicines that are killing people. It is not worth it. The drug companies are making big money and destroying families. Give me a job at the FDA and I will be happy to work there and do an honest days work.

  2. Wayne F says:

    After disabling myself I would not take opoiods for the fear of getting hooked on them after 15 year’s I could no longer take the pain and had no choice if I did not want to spend the rest of what life i had in bed. I damaged myself so bad by not quitting work that I disabled myself . I started having to take opoiods each day to be able to get out of bed, I can lead a simi normal life with them, but do not like it I recommend to friend’s who hurt themself to take the pain as long as they can tolorate it and to only use the medication when it so bad that that you think about ending your life. taking opoiods in a way doe’s take your life, you depend on them and have to have then to avoid a withdrawal. taken only as needed can give you a simi normal life but abuse will take your life one way or another. I have seen it to many times

  3. Hi i am kavin, its my first occasion to commenting anywhere, when i read this piece of writing i thought
    i could also make comment due to this brilliant post.

  4. What’s up to every one, the contents present at this web page are genuinely amazing for people knowledge, well,
    keep up the good work fellows.